Clinical trials for Rectal cancer

173 currently recruiting clinical trials
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05503797 #2024-513578-23-00
Locally Advanced Metastatic BRAF 1 2 3 or more
KRAS G12C KRAS non G12C NRAS HRAS Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 2 more...)
Fore Biotherapeutics
Phase 2 Colon cancer Rectal cancer #NCT06152523 #2024-511857-23-00
Adenocarcinoma Locally Advanced Metastatic MSI/dMMR None 1 2 3 or more Systemic Treatment-Naive Chemotherapy
Immunotherapy Immunotherapy
Hôpital Saint Antoine AP-HP (Paris)
Assistance Publique - Hôpitaux de Paris
Phase 2 Colon cancer Rectal cancer Anal cancer #NCT04954820
Neuroendocrine tumor 1
Systemic Treatment-Naive Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 21 more...)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer #NCT06475352
Locally Advanced Metastatic None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Hospitalier Régional d'Orléans Hôpital de La Source (Orléans), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Centre Hospitalier de la Côte Basque (Bayonne) (and 30 more...)
UNICANCER
Phase 2 Colon cancer Rectal cancer #NCT05706779
Adenocarcinoma Localized BRAF None Systemic Treatment-Naive
KRAS G12C KRAS non G12C NRAS Targeted therapy
Clinique de la Sauvegarde - Ramsay Santé (Lyon), Hôpital Européen Georges Pompidou - AP-HP (Paris), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
Fédération Francophone de Cancérologie Digestive
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT04657068 #2024-511534-12-00
Parties A1, A2, A3 (escalade de dose)
Locally Advanced Metastatic Metastatic Castration-resistant ATM 1 2 3 or more
Systemic Treatment-Naive
Hôpital Saint Louis AP-HP (Paris), Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital de la Timone AP-HM (Marseille)
Artios Pharma Ltd
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B4
Locally Advanced Metastatic Metastatic Castration-resistant ATM 1 2 3 or more
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital de la Timone AP-HM (Marseille), Hôpital Saint Louis AP-HP (Paris)
Artios Pharma Ltd
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B1
Locally Advanced Metastatic Metastatic Castration-resistant ATM 1 2 3 or more
Systemic Treatment-Naive
Hôpital de la Timone AP-HM (Marseille), Hôpital Pitié Salpêtrière - AP-HP (Paris), Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif), Hôpital Saint Louis AP-HP (Paris)
Artios Pharma Ltd
Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT04657068 #2024-511534-12-00
Dose d'expansion Partie B5
Adenocarcinoma Metastatic ATM 2
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Saint Louis AP-HP (Paris)
Artios Pharma Ltd
Phase 1 / Phase 2 Lung cancer Colon cancer Rectal cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer #NCT07169734 #2025-521441-24-00
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Adenocarcinoma Intrahepatic cholangiocarcinoma Urothelial carcinoma Locally Advanced Metastatic 1 2
Gustave Roussy (Villejuif)
Alentis Therapeutics AG